Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis.
Purpose Tyrosine kinase inhibitors (TKIs) are the cornerstones of treatment for patients with chronic myeloid leukaemia (CML). In recent years, several studies were conducted to evaluate the safety of TKIs discontinuation. We performed a systematic review of the literature to determine the incidence...
| Publicado en: | European Journal of Cancer Vol. 77; pp. 48 - 57 |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | research systematic review Journal Article |
| Publicado: |
Pergamon Press - An Imprint of Elsevier Science
May2017
|
| Acceso en línea: | Ver este registro en EBSCOhost |